For many years, corneal injuries or disorders have been one of the leading causes of blindness across the world. The two physician-scientists have decisively changed and accelerated the path to the treatment of these problems. A deeper understanding of the transparent outer layer of the eye, as well as the possibility of ensuring an improved and more cost-effective approach to corneal surgery and transplantation, are essential to tackle this plight.

Zoom-In on Champalimaud: Ana Saraiva Ayash

Zoom-In on Champalimaud: Gonçalo Cotovio

I graduated from NOVA Medical School in 2014, before joining the Champalimaud Foundation’s Neuropsychiatry Unit (NPU) as a research intern the following year. Principally, I have been working on secondary bipolar disorder neuroimaging. 

Since then, I have been fortunate enough to train and work in a variety of institutions, including Centro Hospitalar de Lisboa Ocidental, Harvard Medical School, and since 2017 I have been completing my PhD through a FCT scholarship at the NPU.

Zoom-In on Champalimaud: Charlotte (Charlie) Rosher

Before entering the Champalimaud Foundation, I studied Evolutionary Biology on a Master’s programme that rotated around universities in Uppsala (Sweden), Montpellier (France), Munich (Germany) and Boston (USA). I love seeing the world through the lens of evolution but I have always been focussed in some way on brains and behaviour. Now I am investigating emotions and defensive behaviours for my PhD in the Behavioural Neuroscience lab (Moita lab). 

The Champalimaud Foundation and the IAEA are thus starting a partnership for the development of research, treatment and diagnosis of oncological diseases. The collaboration focuses on the areas of radiation oncology, diagnostic medical imaging, nuclear medicine and medical physics.

Zoom-In on Champalimaud: Justyna Kociolek

Zoom-In on Champalimaud: Ana Carolina Pádua

I hold a Master’s degree in Biomedical Engineering and a PhD in Molecular Biosciences from NOVA University, Lisbon. After completing my PhD project, I moved to Texas (USA) for an internship in High-Performance Computing. This experience allowed me to discover how supercomputers can contribute to making science more efficient and productive. 
 

Among neurological disorders, which are now the world’s leading cause of disability, Parkinson’s disease (PD) is the fastest growing. With over 6 million individuals affected worldwide, that number is expected to reach over 12 million by 2040.

Zoom-In on Champalimaud: João Lourenço

I graduated in Medicine in 2001, a Radiology specialist since 2006, and I have been working in the Imaging Department of the Champalimaud Clinical Centre for about five years. I perform diagnostic exams such as ultrasound, CT and MRI, image-guided biopsies and drainage procedures, as well as advise colleagues from other specialties. I am also involved, as a Radiologist, in several ongoing research projects and clinical trials.

Zoom-In on Champalimaud: Terufumi Fujiwara

I received my Ph.D. from the University of Tokyo, Japan, and joined Eugenia Chiappe's lab as a postdoc in 2013. I am studying how the brain monitors and controls walking movements by combining patch-clamp electrophysiology and head-fixed behaviour in the fruit fly animal model. I will be moving back to Japan and starting my lab at Riken in November 2022!